Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |